Steven C. Gilman, Ph.D.
DirectoratAkebia Therapeutics· In proxies 2024–2025
Steven C. Gilman, Ph.D. sits on 2 public boards.
Boards1
- Akebia TherapeuticsDirector · 6 yr on the boardIndependentCompensation, Research & Development—Paid as an executive
Board seats come from each company's latest proxy statement.
Experience
- Akebia TherapeuticsPublic company · 2 yr
- Director2024 – Present · 2 yrStock in role -36%
- KeryxPublic company
- Director? – PresentNo stock prices for these years
Roles come from the proxy statements of each company.
Activity
No new filings about this person in the feed.
Two people shown as one, or a wrong number?